Get the Stockscreener App
8.57
0.12%
-0.010
Y Mabs Therapeutics Inc stock is traded at $8.57, with a volume of 522.28K.
It is down -0.12% in the last 24 hours and up +104.53% over the past month.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
See More
Previous Close:
$8.58
Open:
$8.57
24h Volume:
522.28K
Relative Volume:
0.64
Market Cap:
$389.41M
Revenue:
$84.82M
Net Income/Loss:
$-21.43M
P/E Ratio:
-17.49
EPS:
-0.49
Net Cash Flow:
$-27.23M
1W Performance:
+0.35%
1M Performance:
+104.53%
6M Performance:
+72.78%
1Y Performance:
-40.32%
1-Day Range:
$8.56
$8.58
1-Week Range:
$8.54
$8.58
52-Week Range:
$3.55
$16.11
Y Mabs Therapeutics Inc Stock (YMAB) Company Profile
Name
Y Mabs Therapeutics Inc
Sector
Industry
Phone
646-885-8505
Address
202 CARNEGIE CENTER, PRINCETON, NY
Compare YMAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YMAB
Y Mabs Therapeutics Inc
|
8.57 | 388.95M | 84.82M | -21.43M | -27.23M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Y Mabs Therapeutics Inc Stock (YMAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-18-24 | Initiated | Oppenheimer | Outperform |
| Aug-16-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-28-24 | Initiated | Truist | Buy |
| May-10-23 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-27-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-05-23 | Downgrade | Cowen | Outperform → Market Perform |
| Dec-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-31-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-31-22 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Jun-24-22 | Initiated | BMO Capital Markets | Outperform |
| Feb-03-22 | Resumed | Guggenheim | Buy |
| Nov-19-21 | Resumed | Morgan Stanley | Equal-Weight |
| Nov-16-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-07-21 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-23-21 | Resumed | Cowen | Outperform |
| Mar-22-21 | Resumed | JP Morgan | Overweight |
| Jan-15-21 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-09-20 | Reiterated | H.C. Wainwright | Buy |
| May-05-20 | Initiated | Barclays | Overweight |
| May-01-20 | Initiated | Janney | Buy |
| Apr-29-20 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-24-19 | Initiated | JP Morgan | Overweight |
| Nov-20-19 | Initiated | Guggenheim | Buy |
| Sep-04-19 | Initiated | Wedbush | Outperform |
| Apr-01-19 | Initiated | H.C. Wainwright | Buy |
| Oct-16-18 | Initiated | BTIG Research | Buy |
| Oct-16-18 | Initiated | BofA/Merrill | Buy |
View All
Y Mabs Therapeutics Inc Stock (YMAB) Latest News
Is Y mAbs Therapeutics Inc. stock risky to hold nowMarket Weekly Review & Accurate Buy Signal Notifications - khodrobank.com
Sector ETF performance correlation with Y mAbs Therapeutics Inc.Market Trend Report & Reliable Price Breakout Alerts - Newser
How to escape a deep drawdown in Y mAbs Therapeutics Inc.Market Trend Review & Weekly Hot Stock Watchlists - Newser
Published on: 2025-09-04 23:05:35 - Newser
Can Y mAbs Therapeutics Inc. disrupt its industryEarnings Recap Report & AI Enhanced Trading Signals - khodrobank.com
Custom strategy builders for tracking Y mAbs Therapeutics Inc.Breakout Watch & Daily Chart Pattern Signal Reports - Newser
Exit strategy if you’re trapped in Y mAbs Therapeutics Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Can volume confirm reversal in Y mAbs Therapeutics Inc.July 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Intraday pattern recognizer results for Y mAbs Therapeutics Inc.Trade Risk Summary & Weekly High Potential Alerts - Newser
Is Y mAbs Therapeutics Inc. impacted by rising ratesGlobal Markets & Trade Opportunity Analysis - khodrobank.com
Will Y mAbs Therapeutics Inc. stock go up soonBull Run & Daily Stock Momentum Reports - Newser
Detecting support and resistance levels for Y mAbs Therapeutics Inc.Dip Buying & Stepwise Trade Signal Implementation - Newser
Signal strength of Y mAbs Therapeutics Inc. stock in tech scannersWeekly Market Report & Weekly High Conviction Trade Ideas - Newser
Is Y mAbs Therapeutics Inc. trading at a discountJuly 2025 Movers & Fast Gaining Stock Strategy Reports - khodrobank.com
Tools to monitor Y mAbs Therapeutics Inc. recovery probabilityTrade Risk Assessment & Free Daily Entry Point Trade Alerts - Newser
Real time breakdown of Y mAbs Therapeutics Inc. stock performanceJuly 2025 Intraday Action & Long-Term Investment Growth Plans - Newser
Custom watchlist performance reports with Y mAbs Therapeutics Inc.July 2025 Levels & Safe Capital Investment Plans - Newser
Does Y mAbs Therapeutics Inc. fit your quant trading modelJuly 2025 Setups & Safe Swing Trade Setup Alerts - Newser
Chart based exit strategy for Y mAbs Therapeutics Inc.Trade Risk Summary & Detailed Earnings Play Alerts - Newser
Aug Big Picture: Is Y mAbs Therapeutics Inc. impacted by rising ratesMarket Weekly Review & High Conviction Buy Zone Alerts - خودرو بانک
Can Y mAbs Therapeutics Inc. navigate macro headwindsJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - khodrobank.com
What is the long term forecast for Y mAbs Therapeutics Inc. stockJuly 2025 Weekly Recap & Weekly Top Stock Performers List - خودرو بانک
Is Y mAbs Therapeutics Inc. forming bullish engulfing patternsEarnings Overview Report & Growth Focused Stock Reports - khodrobank.com
Can Y mAbs Therapeutics Inc. stock double in the next yearQuarterly Earnings Summary & High Accuracy Swing Entry Alerts - khodrobank.com
Y mAbs Therapeutics Inc. stock retracement – recovery analysis2025 Market WrapUp & Verified Momentum Stock Watchlist - Newser
Y mAbs Therapeutics Inc. stock volume spike explainedPortfolio Value Report & AI Enhanced Trading Alerts - Newser
How to use Fibonacci retracement on Y mAbs Therapeutics Inc.Rate Hike & Precise Swing Trade Entry Alerts - Newser
Is Y mAbs Therapeutics Inc. stock a hidden gem2025 Price Action Summary & Low Drawdown Momentum Ideas - khodrobank.com
Can Y mAbs Therapeutics Inc. scale operations efficiently2025 Volatility Report & Stepwise Trade Execution Plans - khodrobank.com
Can Y mAbs Therapeutics Inc. stock outperform in a bear marketTrade Volume Report & Long Hold Capital Preservation Plans - khodrobank.com
Can Y mAbs Therapeutics Inc. continue delivering strong returns2025 Bull vs Bear & Low Volatility Stock Recommendations - khodrobank.com
Using R and stats models for Y mAbs Therapeutics Inc. forecastingWeekly Trend Recap & Reliable Price Breakout Signals - Newser
Can Y mAbs Therapeutics Inc. outperform in the next rallyRecession Risk & AI Powered Market Entry Ideas - khodrobank.com
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy? - sharewise.com
Chart based analysis of Y mAbs Therapeutics Inc. trends2025 Market Trends & Real-Time Buy Zone Alerts - Newser
What institutional flow reveals about Y mAbs Therapeutics Inc.Earnings Risk Report & Verified Swing Trading Watchlists - Newser
YmAbs Therapeutics (YMAB) Surges 103.3%: Is This an Indication of Further Gains? - MSN
Y Mabs Therapeutics Inc Stock (YMAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Y Mabs Therapeutics Inc Stock (YMAB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rossi Michael J | PRESIDENT & CEO |
Mar 07 '25 |
Sale |
5.20 |
3,917 |
20,368 |
137,083 |
| Gad Thomas | CHIEF BUSINESS OFFICER |
Mar 07 '25 |
Sale |
5.23 |
10,810 |
56,536 |
202,721 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):